Featured Publications
Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis
Galvao R, Curtis J, Harrold L, Wu Q, Xie F, George M. Accuracy of administrative claims prescription fill data to estimate glucocorticoid use and dose in patients with rheumatoid arthritis. Pharmacoepidemiology And Drug Safety 2023, 32: 1271-1279. PMID: 37345649, PMCID: PMC10543479, DOI: 10.1002/pds.5660.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedArthritis, RheumatoidGlucocorticoidsHumansMedicareOdds RatioPrescriptionsUnited StatesConceptsGlucocorticoid usePrescription fillsExposure misclassificationRheumatoid arthritisInfection riskRisk estimatesAdjusted risk ratioPhysician-reported measuresDeterministic sensitivity analysesRisk ratioMedicare studyRegistry dataClaims dataAverage doseNPV 93.6Sensitivity 88.1DoseArthritisPatientsPrescriptionRiskDosesSame periodPrior studiesMisclassification
2020
Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices
Calabrese SK, Galvao RW, Dovidio JF, Willie TC, Safon CB, Kaplan C, Caldwell A, Blackstock O, Phillips NJ, Kershaw TS. Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices. AIDS Patient Care And STDs 2020, 34: 132-146. PMID: 32202930, PMCID: PMC7087409, DOI: 10.1089/apc.2019.0242.Peer-Reviewed Original ResearchConceptsPrEP modalitiesDaily pillContraception practicesHIV pre-exposure prophylaxisPre-exposure prophylaxisLow uptakePlanned Parenthood centersWomen ages 18Non-Hispanic blacksWomen's preferencesExposure prophylaxisPrEP acceptabilityPrEP uptakeHIV incidenceBirth control practicesActive womenVaginal ringHigher oddsCommon reasonSexual healthReproductive healthSociodemographic characteristicsAge 18WomenPills
2019
Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
Calabrese SK, Willie TC, Galvao RW, Tekeste M, Dovidio JF, Safon CB, Blackstock O, Taggart T, Kaplan C, Caldwell A, Kershaw TS. Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2019, 81: 395-405. PMID: 30973543, PMCID: PMC6594908, DOI: 10.1097/qai.0000000000002042.Peer-Reviewed Original ResearchMeSH KeywordsAnti-HIV AgentsFemaleGuidelines as TopicHealth Knowledge, Attitudes, PracticeHIV InfectionsHIV SeropositivityHumansMaleMotivationPatient Acceptance of Health CarePre-Exposure ProphylaxisRisk FactorsRisk-TakingSexual PartnersSexually Transmitted DiseasesSurveys and QuestionnairesUnited StatesConceptsHIV pre-exposure prophylaxisPrEP eligibilityPre-exposure prophylaxisIndication criteriaPrEP accessHIV riskWomen's knowledgeDisease controlHigh self-perceived riskHIV-risk indicatorsPrevention clinical guidelinesHIV-negative womenCurrent US guidelinesSelf-perceived riskPlanned Parenthood centersMultiple sex partnersNon-Hispanic whitesPartners' HIV riskVersion of CentersPrEP useHIV protectionOwn risk behaviorsClinical guidelinesPrevention criteriaCurrent guidelines